The Medicare program effectively reduced insulin costs, improved adherence, and increased plan enrollment, benefiting both patients and the federal government. The initiative involved major insulin ...

As anyone who’s gone on a diet knows, once you lose some weight, it gets harder to lose more. The “eat less, move more” mantra, as simple as it sounds, doesn’t help us deal with our bodies’ metabolic ...

One promising new strategy to treat diabetes is to give patients insulin that circulates in their bloodstream, staying dormant until activated by rising blood sugar levels. However, no ...

Statistics from the Centers for Disease Control and Prevention (CDC) show that obesity affects more than 40% of American adults, placing them at higher risk for heart disease, stroke, type 2 diabetes, ...

Making a big stride in the cost of ongoing medical care for diabetics, Medicare has worked to establish an insulin price cap. Going into effect in 2021, a $35 copay for insulin may help save Medicare ...

Researchers have created a computer model that can predict how glucose-responsive insulin will affect patients' blood sugar based on chemical traits such as how quickly it becomes activated in the ...

The Centers for Medicare and Medicaid Services on Tuesday announced a partnership with the nation's three largest insulin makers – Eli Lilly, Novo Nordisk, and Sanofi – to cap the copay cost of ...

In a Perspective, John Speakman and Kevin Hall suggest that, while insulin does play a role in body fat regulation, it does so independent of dietary carbohydrates. Thus, low-carb, high-fat diets - ...

Beneficiaries who use insulin and join a plan participating in the voluntary model, beginning January 2021, could see average out-of-pocket savings of $446. Insulin copays for beneficiaries in ...

From day one, President Trump has been dedicated to lowering the cost of prescription drugs and has directed the Centers for Medicare and Medicaid Services (CMS) to take action. In 2017, we made ...